Concepedia

Methylated Tissue Factor Pathway Inhibitor 2 (TFPI2) DNA in Serum Is a Biomarker of Metastatic Melanoma

Cristiana Lo Nigro, Hexiao Wang, Angela McHugh, Laura Lattanzio, Rubeta Matin, Catherine Harwood, Nelofer Syed, Eleftheria Hatzimichael, Evangelos Briasoulis, Marco Merlano,

Journal of Investigative Dermatology · 2013 · 50 citations · 14 references

DOIFull text

Open access

Concepts

References

14

Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

Paul B. Chapman, Axel Hauschild, Caroline Robert et al. · New England Journal of Medicine · 2011 · 7.7K citations · Full text

, , +9

Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma

Keith T. Flaherty, Caroline Robert, Peter Hersey et al. · New England Journal of Medicine · 2012 · 2.1K citations · Full text

, , +17

Improved survival with MEK Inhibition in BRAF-mutated melanoma for the METRIC Study Group

Keith T. Flaherty, Caroline Robert, Peter Hersey et al. · Zurich Open Repository and Archive (University of Zurich) · 2012 · 1.3K citations

, , +15

Identification of novel epigenetically modified genes in human melanoma via promoter methylation gene profiling

Suhu Liu, Suping Ren, Paul Howell et al. · Pigment Cell & Melanoma Research · 2008 · 133 citations

, , +17

Sequencing of BRAF inhibitors and ipilimumab in patients with metastatic melanoma: a possible algorithm for clinical use

Paolo A. Ascierto, Ester Simeone, Diana Giannarelli et al. · Journal of Translational Medicine · 2012 · 124 citations · Full text

, , +17